StreetAlpha.app
Home › Stocks › NTHI

Neonc Technologies Holdings, Inc. (NTHI)

$3.15
▼ −9.48%
LAST CLOSE · NOV 20

NeOnc Technologies develops drug candidates for brain cancers, including NEO100 and NEO212, which are still in clinical trials. It last closed at $3.15 on Nov 20, down 9.48% on the day. The next earnings report for NTHI is expected around Fri, Apr 2, 2027, after the close. For the quarter ended Sep 2026, NTHI reported EPS of -$0.28 on revenue of $0. Over its last 6 reports the stock moved an average of 8.7% the session after earnings. Over the last 12 months NTHI insiders bought $2.0M of stock on the open market and sold $0, according to SEC Form 4 filings.

AI Auto Pilots
Is NTHI in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NTHI.

Key Stats

Last 12 months
Results
Revenue
$0
−100.0% vs a year ago
Net income
−$43.0M
EPS (diluted)
−$1.95
Valuation
Market cap
$90.9M
28.9M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$6.2M
At Sep 30
Shareholder equity
−$13.2M
Shares outstanding
28.9M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2024: $83K$83KFY2024FY2025: $40K$40KFY2025

From NTHI's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Apr 2
Estimated date · After the close
Reported EPS
-$0.28
Quarter ended Sep 2026
Year ago EPS
-$0.45
Same quarter last year
Revenue
$0
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.13Dec '24Mar 2025: -$1.78Mar '25Jun 2025: -$0.30Jun '25Sep 2025: -$0.45Sep '25Dec 2025: -$0.72Dec '25Mar 2026: -$0.38Mar '26Jun 2026: -$0.58Jun '26Sep 2026: -$0.28Sep '26Latest -$0.28
Revenue by quarter
Dec 2024: $20,000Dec '24Mar 2025: $39,990Mar '25Jun 2025: $0Jun '25Sep 2025: $0Sep '25Dec 2025: $0Dec '25Jun 2026: $0Jun '26Sep 2026: $0Sep '26Latest $0
How NTHI moved after its last 6 reports
Average move the session after a report ±8.7%
Nov 5, 2026After the close+9.1%
Aug 10, 2026After the close+24.3%
May 18, 2026After the close+2.6%
Apr 3, 2026After the close−3.5%
Nov 14, 2025After the close−12.3%
Aug 22, 2025After the close−0.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on NTHIStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on NTHI
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on NTHI

Technical Analysis

NTHI · as of the Nov 20 close · updated each morning
Moving sideways

The stock is 16% below its 20 day and 4% below its 50 day average. It is 61% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 42). The nearest support is the swing low (Aug 13) at $3.13, and the nearest resistance the Pivot at $3.27.

Short trendNeutral
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 17.1%/day
Key levels
$11.3852 week high+261.3%
$5.08200 day average+61.3%
$3.67100 day average+16.5%
$3.6620 day average+16.2%
$3.44Pivot R1+9.2%
$3.38Swing high (Oct 30)+7.3%
$3.2950 day average+4.4%
$3.27Pivot+3.8%
$3.15Last close
$3.13Swing low (Aug 13)−0.6%
$2.98Pivot S1−5.4%
$2.5052 week low−20.6%
Indicators
RSI (14)41.90Middle of its rangeNeutral
MACD0.21Below its signal lineBearish
Stochastic27.1Middle of its rangeNeutral
ADX (14)36.0Trending up
Williams %R-90.5Oversold below −80, overbought above −20Oversold
CCI (20)-45.9Oversold below −100, overbought above 100Neutral
Rate of change−9.7%Change over 10 sessionsBearish
ATR (14)$0.54Typical daily range, 17.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for NTHI

What happened before

See how NTHI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Whale Options Flow

90D
Whale options flow for NTHIHow many large options trades hit NTHI, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

NTHI Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲12 buying vs 5 selling
  • ▲Held by funds +6.2 pts
  • ▲Funds holding +6
  • ▲Superinvestors: 1 added, 0 cut
  • ●Put/call not meaningful
Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding2721+28.6%
In funds' top 1000–
Held by funds17.1%10.9%+6.2 pts
New / increased6 / 61 / 10+9.1%
Reduced / sold out5 / 04 / 8−58.3%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NTHI institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

NTHI Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$2.0M23 buys · 5 insiders
Sold$00 sales · 0 insiders
Cluster buy: 2 insiders bought $734K between Nov 5 and Nov 13.
2026-04 bought $382K2026-05 bought $42K2026-08 bought $318K2026-09 bought $351K2026-11 bought $734KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 13Amir F HeshmatpourCEO, PresidentBuy30,000$5.02$151K
Nov 11Amir F HeshmatpourCEO, PresidentBuy70,000$4.21$295K
Nov 10Thomas C ChenCmoBuy5,016$3.99$20K
Nov 9Amir F HeshmatpourCEO, PresidentBuy10,000$3.86$39K
Nov 6Amir F HeshmatpourCEO, PresidentBuy70,000$3.29$231K
Sep 15Amir F HeshmatpourCEO, PresidentBuy50,000$3.50$175K
Every insider buy and sale for NTHI over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See NTHI insider trades →

From SEC Form 4 filings by NTHI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NTHI is in one of them and how their past NTHI trades turned out.

NTHI in the AI portfolios
Loading…

NTHI News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NTHI in an article yet. Here's the latest on the wider market.

NTHI in the news

About Neonc Technologies Holdings

NeOnc Technologies develops drugs for cancers that start in the brain or spread there, including glioblastoma, meningioma and brain metastases from lung, breast and skin cancers. Its lead candidates are NEO100, a purified form of perillyl alcohol given by nasal spray, and NEO212, an oral drug that combines temozolomide with perillyl alcohol. The company has no approved products yet and is testing its candidates in trials with patients who have brain tumors. It is based in Calabasas, California.

Headquarters
Calabasas, CA